Created at:1/13/2025
I-Caplacizumab iyimithi ekhethekile esiza ukwelapha isifo esingavamile kodwa esibucayi sokujiya kwegazi esibizwa ngokuthi i-thrombotic thrombocytopenic purpura (TTP). Lesi simo sibangela ukuthi kwakheke amahlule egazi ayingozi emzimbeni wakho wonke ngenkathi futhi kubhubhisa ama-platelets akho, amaseli asiza igazi lakho ukuthi lijiye ngokujwayelekile.
Cabanga nge-caplacizumab njengomsizi oqondiwe ongena lapho uhlelo lwakho lokujiya kwegazi lungahambi kahle. Lusebenza kanye nezinye izindlela zokwelapha ukusiza ukubuyisela ibhalansi nokuvimbela izinkinga ezisongela impilo. Ngenkathi i-TTP ithinta abantu abambalwa kuphela ngamunye ezigidini ngonyaka, ukuba nokwelashwa okuphumelelayo njenge-caplacizumab kungenza umehluko omkhulu kulabo abayidingayo.
I-Caplacizumab iyi-antibody eyenziwe e-laboratory eqondiswe ngqo kuphrotheni ebizwa ngokuthi i-von Willebrand factor egazini lakho. Le phrotheni ngokuvamile isiza igazi lakho ukuthi lijiye uma ulimele, kodwa ku-TTP, iba ngaphezu kwamandla futhi ibangela ukuthi kwakheke amahlule ayingozi emithanjeni emincane yegazi.
Lo muthi ungowesigaba semithi ebizwa ngokuthi ama-monoclonal antibodies. Lezi zenzelwe ukuthi zibone futhi zibophele ezintweni ezithile emzimbeni wakho ngokunemba okumangalisayo. Endabeni ye-caplacizumab, ibambelela ku-von Willebrand factor enezinkinga futhi ivimbele ukuthi ingabangeli ukujiya okuyingozi okubonisa i-TTP.
Ungase ubone lo muthi ubizwa ngegama lawo eliphelele, i-caplacizumab-yhdp, noma ngegama lawo lomkhiqizo i-Cablivi. Ingxenye ethi "yhdp" imane nje iyisijobelelo esisiza ukuhlukanisa le nguqulo ethile kwezinye izindlela ezingaba khona.
I-Caplacizumab ivunyelwe ngokuqondile ukwelapha abantu abadala abane-thrombotic thrombocytopenic purpura (TTP) etholakele. Lokhu kuyisimo esiphuthumayo sezokwelapha lapho amasosha akho omzimba ehlasela ngempela i-enzyme evame ukwephula i-von Willebrand factor, okuholela ezinkingeni eziningi zokujiya kwegazi.
I-TTP ingabangela izinkinga ezingathi sína emzimbeni wakho wonke ngoba lawa magazi amancane angavimba ukuhamba kwegazi ezingxenyeni ezibalulekile zomzimba njengobuchopho bakho, inhliziyo, nezinso. Ngaphandle kokwelashwa, lesi simo singabulala. Kodwa-ke, uma sibanjwe ngokushesha futhi selashwa ngendlela efanele ngemithi efana ne-caplacizumab kanye nokwelashwa ngokushintshaniswa kwe-plasma, abantu abaningi bayalulama kahle.
Udkt wakho ngokuvamile uzonikeza i-caplacizumab njengengxenye yohlelo lokwelapha olubanzi oluhlanganisa ukushintshaniswa kwe-plasma, inqubo esusa ama-antibody anezinkinga egazini lakho futhi iwashintshe nge-plasma enempilo. Umuthi usiza ukuvala igebe ngenkathi lezi ezinye izindlela zokwelapha zisebenza ukubhekana nenkinga eyisisekelo yamasosha omzimba.
I-Caplacizumab isebenza ngokuvimba isenzo sama-multimer amakhulu e-von Willebrand factor, okuyizona ezidala izinkinga ku-TTP. Lezi zinhlobo zamaprotheni ngokuvamile zisiza ukwakha amahlule egazi uma ulimele, kodwa ku-TTP, ziba zinkulu futhi zinamathela ngokungavamile, okubangela ukuthi amahlule akheke lapho kungafanele khona.
Uma uthola i-caplacizumab, ibopha engxenyeni ethile yala ma-multimer e-von Willebrand factor ebizwa ngokuthi i-A1 domain. Lokhu kubavimbela ukuthi banganamatheli kuma-platelet akho futhi bakhe amahlule ayingozi abonisa i-TTP. Kufana nokubeka i-coating evikelayo kuma-protein anezinkinga ukuze angakwazi ukulimaza.
Umuthi uthathwa njengokwelashwa okuhloswe ngakho ngoba ubhekana ngqo nesizathu esiyisisekelo sokujiya kwegazi ku-TTP ngaphandle kokuthinta kabanzi ikhono lomzimba wakho lokujiya igazi elivamile. Lokhu kunemba kusiza ukunciphisa imiphumela emibi ngenkathi iphatha ngempumelelo lesi simo. Abantu abaningi baqala ukubona ngcono ekubalweni kwabo kwe-platelet ezinsukwini ezimbalwa ngemuva kokuqala ukwelashwa.
I-Caplacizumab inikezwa njengomjovo, kungaba emthanjeni (i-intravenous) noma ngaphansi kwesikhumba (i-subcutaneous). Ithimba lakho lezempilo ngokuvamile lizoqala ngomthamo we-intravenous ngaphambi nje komhlangano wakho wokuqala wokushintshanisa i-plasma, kulandelwe imijovo yansuku zonke ye-subcutaneous.
Imijovo ye-subcutaneous ivame ukunikezwa ezindaweni ezinamafutha, njengethanga lakho, ingalo engenhla, noma isisu. Umhlinzeki wakho wezempilo uzokufundisa wena noma ilungu lomndeni ukuthi unganikeza kanjani le mijovo ngokuphepha ekhaya. Kubalulekile ukushintshanisa izindawo zomjovo ukuvimbela ukucasuka kwesikhumba futhi uqinisekise ukuthi umuthi umuncwa kahle.
Akudingeki ukhathazeke ngesikhathi se-caplacizumab ngokudla ngoba inikezwa njengomjovo kunokuba ithathwe ngomlomo. Kodwa-ke, kufanele uzame ukunikeza umjovo wakho wansuku zonke cishe ngesikhathi esifanayo nsuku zonke ukuze ugcine amazinga aqhubekayo omuthi ohlelweni lwakho.
Njalo gcina umuthi efrijini uze ulungele ukuwusebenzisa, kodwa wuvumele ukuthi ufudumale ekamelweni lokushisa ngaphambi kokujova. Lokhu kusiza ukunciphisa ukungakhululeki endaweni yomjovo.
Abantu abaningi bathatha i-caplacizumab cishe izinsuku ezingama-30, kodwa isikhathi esiqondile sincike ekutheni usabela kahle kangakanani ekwelashweni nokuthi ngokushesha kangakanani ukubala kwakho kwamaplatelet kubuyela kokujwayelekile. Udokotela wakho uzoqapha umsebenzi wakho wegazi ngokucophelela ukuze anqume ukuthi kuphephile nini ukuyeka umuthi.
Ukwelashwa ngokuvamile kuqhubeka okungenani izinsuku ezingama-30 ngemuva komhlangano wakho wokugcina wokushintshanisa i-plasma, uma nje ukubala kwakho kwamaplatelet kuhlala kuzinzile ngaphezu kuka-150,000 ngemayikrolitha ngalinye. Abanye abantu bangase badinge ukuyithatha isikhathi eside uma ukululama kwabo kuthatha isikhathi esiningi noma uma behlangabezana nezinkinga.
Ungayeki ukuthatha i-caplacizumab ngokuzumayo noma ngaphandle kokukhuluma nodokotela wakho kuqala. I-TTP ingabuyela uma ukwelashwa kuyekwa ngokushesha kakhulu, ngakho ithimba lakho lezempilo lizokugada ngokucophelela isimo sakho ngaphambi kokwenza noma yiziphi izinguquko ohlelweni lwakho lokwelashwa.
Njengazo zonke izidakamizwa, i-caplacizumab ingabangela imiphumela emibi, nakuba kungewona wonke umuntu oyitholayo. Imiphumela emibi evame kakhulu ngokuvamile imnene futhi ingalawuleka ngokunakekelwa okufanele nokuqapha.
Nansi imiphumela emibi ongase uhlangabezane nayo, ukhumbula ukuthi ithimba lakho lezempilo lilungele ukukusiza ukulawula noma yikuphi okuvelayo:
Ukuthambekela okuqhubekayo kokuphuma kwegazi yimiphumela emibi ebaluleke kakhulu okufanele iqashelwe ngoba i-caplacizumab ithinta ikhono legazi lakho lokujiya. Lokhu kuvamile ukuba mnene, kodwa kubalulekile ukuqaphela kakhulu ukugwema ukulimala nokubika noma yikuphi ukuphuma kwegazi okungavamile eqenjini lakho lezempilo ngokushesha.
Nakuba kungavamile, abanye abantu bangase babe nemiphumela emibi engathi sína edinga ukunakekelwa kwezempilo ngokushesha. Lokhu kuhlanganisa ukuphuma kwegazi okukhulu okungayeki ngengcindezi, izimpawu zokuphuma kwegazi kwangaphakathi njengendle emnyama noma enegazi, noma ukusabela okukhulu komzimba. Ithimba lakho lezempilo lizoxoxa nawe ngalezi zimpawu zokuxwayisa futhi linikeze imiyalelo ecacile yokuthi kufanele ufune nini ukunakekelwa okuphuthumayo.
I-Caplacizumab ayifanele wonke umuntu, futhi udokotela wakho uzohlola ngokucophelela ukuthi ingabe iyona ndlela efanele esimweni sakho esithile. Abantu abanezimo ezithile zezokwelapha noma izimo bangase badinge ukwelashwa okuhlukile.
Udkt. wakho cishe uzoncoma indlela ehlukile uma unezimo ezithile ezingenza i-caplacizumab ibe yingozi kuwe:
Ubudala ngokwabo ngokuvamile abuyona into evimbela ukwelashwa, kodwa udokotela wakho uzocabangela isimo sakho sempilo esiphelele neminye imithi oyithathayo. Bazohlola futhi noma yiziphi izinqubo ezizayo noma ukuhlinzwa okungase kwenyuse ingozi yakho yokopha ngenkathi usebenzisa i-caplacizumab.
Uma uthatha ama-blood thinners noma eminye imithi ethinta ukujiya kwegazi, udokotela wakho uzolinganisela ngokucophelela izinzuzo nezingozi. Kwesinye isikhathi ukulinganisa noma isikhathi seminye imithi kudingeka kulungiswe ukuze kusetshenziswe i-caplacizumab ngokuphepha.
I-Caplacizumab ithengiswa ngaphansi kwegama lomkhiqizo elithi Cablivi. Leli yilo kuphela igama lomkhiqizo elitholakala njengamanje kule mithi, njengoba kuyindlela yokwelapha entsha futhi ekhethekile eyenzelwe ngqo i-TTP.
Ungase ubone igama eliphelele lobuchwepheshe libhalwe njenge-caplacizumab-yhdp emadokhumentini athile ezokwelapha noma imiyalelo kadokotela. Ingxenye ethi "yhdp" iyisijobelelo esisiza ukukhomba le fomula ethile yomuthi, kodwa abantu abaningi bamane babhekisele kuyo njenge-caplacizumab noma ngegama layo lomkhiqizo elithi Cablivi.
Njengoba le kuyimithi ekhethekile yesimo esingavamile, ngokuvamile itholakala kuphela ngemithi ekhethekile noma ngokuqondile ezibhedlela. Ithimba lakho lezempilo lizosiza ukuxhumanisa ukuthola imithi futhi liqinisekise ukuthi unokufinyelela endaweni efanele yokugcina kanye nezinto zokujova.
Njengamanje, akukho okunye okuqondile ku-caplacizumab okusebenza ngendlela efanayo. Kodwa-ke, ukwelashwa kwe-TTP kuhilela izindlela eziningi ezisebenza ndawonye, kanti udokotela wakho unezinketho eziningana zokusiza ukuphatha isimo sakho ngempumelelo.
Isisekelo sokwelashwa kwe-TTP sihlala i-plasma exchange therapy, esusa ngokomzimba ama-antibody anezinkinga egazini lakho futhi iwashintshe nge-plasma enempilo. Lokhu kwelashwa kuvame ukuhlanganiswa nemithi ecindezela amasosha omzimba njengama-corticosteroids ukusiza ukuthulisa ukuhlasela kwamasosha omzimba akho ku-enzyme yokujiya.
Kwezinye izimo, udokotela wakho angase ancome i-rituximab, umuthi oqondiswe ezingxenyeni ezithile zamasosha omzimba abangela ukukhiqizwa kwama-antibody ayingozi. Lokhu kungaba usizo ikakhulu kubantu ababa neziqephu eziphindaphindayo ze-TTP noma abangaphenduli kahle ekwelashweni okujwayelekile.
Kubantu abangakwazi ukusebenzisa i-caplacizumab ngenxa yezingozi zokuphuma kwegazi noma ezinye izinto ezingavumelani, ukugxila kushintshela ekuthuthukiseni imvamisa yesikhathi se-plasma exchange, kanye nokuphathwa ngokucophelela kwamasosha omzimba. Ithimba lakho lezempilo lizosebenza nawe ukuthola inhlanganisela engcono kakhulu yokwelashwa yesimo sakho esithile.
I-Caplacizumab imelela intuthuko enkulu ekwelashweni kwe-TTP, kodwa isebenza kahle kakhulu uma isetshenziswa njengengxenye yohlelo lokwelapha olubanzi kunokuba kube yitherape eyodwa. Izifundo zemitholampilo zikhombisile ukuthi ukwengeza i-caplacizumab ku-plasma exchange therapy ejwayelekile kungasiza abantu ukuthi balulame ngokushesha futhi kunciphise ingozi yezinkinga ezihlobene ne-TTP.
Inzuzo enkulu ye-caplacizumab ukuthi ingaphazamisa ngokushesha inqubo yokujiya egazini ebangela izimpawu ze-TTP, ngokuvamile eholela ekululameni okusheshayo kokubala kwamapuleti kanye nokuhlala esibhedlela okufushane. Lokhu kungaba usizo ikakhulu ngesikhathi sokuqala sokwelashwa lapho ukulimala kwezitho kungenzeka kakhulu.
Noma kunjalo, i-caplacizumab ayithathi indawo yokushintshaniswa kwe-plasma noma ukwelashwa kwamasosha omzimba ngoba ayibhekisisi imbangela ye-TTP. Kunalokho, ithenga isikhathi esibalulekile sokuthi lezi ezinye izindlela zokwelapha zisebenze. Cabanga ngayo njengebhuloho elisiza ukuzinzisa isimo sakho ngenkathi ukwelashwa okucacile kuqala ukusebenza.
Udokotela wakho uzocabangela izinto ezinjengobunzima besimo sakho, ingozi yakho yokopha, nokuthi usabela ngokushesha kangakanani ekushintshanisweni kwe-plasma lapho enquma ukuthi i-caplacizumab ingeyona yini into efanele ukuyengeza ohlelweni lwakho lokwelapha. Kubantu abaningi, indlela yokuhlanganisa inikeza ithuba elingcono kakhulu lokululama ngokugcwele.
I-Caplacizumab ngokuvamile ingasetshenziswa ngokuphepha kubantu abanezifo zenhliziyo, kodwa udokotela wakho wenhliziyo kanye nethimba lakho lokwelapha i-TTP kuzodingeka basebenzisane ukuze baphathe ukunakekelwa kwakho. Imiphumela yokunciphisa igazi yomuthi ingase ikwazi ukwandisa ingozi yokopha uma futhi uthatha imithi yenhliziyo efana ne-warfarin noma i-aspirin.
Odokotela bakho bazolinganisela ngokucophelela ingozi esongela impilo ye-TTP engalashwanga ngokumelene nezinkinga ezingaba khona zokopha. Ezimweni eziningi, ingozi esheshayo evela ku-TTP idlula ukukhathazeka ngokopha, kodwa imithi yakho yenhliziyo ingase idinge ukulungiswa okwesikhashana ngenkathi uthola ukwelashwa nge-caplacizumab.
Uma ngengozi uzifaka i-caplacizumab eningi kunaleyo ebekiwe, xhumana nomhlinzeki wakho wezempilo noma funa usizo oluphuthumayo lwezokwelapha ngokushesha. Ukweqisa kungase kwandise kakhulu ingozi yakho yokopha futhi kudingeke ukuqapha kwezokwelapha noma ukungenelela.
Ungazami ukulungisa ngokweqa umthamo wakho olandelayo noma ukunciphisa imithamo yesikhathi esizayo ngokwakho. Kunalokho, letha ukupakishwa komuthi nawe ukuze usize abahlinzeki bezempilo baqonde kahle okwenzekile futhi banikeze ukunakekelwa okufanele. Bangase bafune ukuhlola umsebenzi wegazi lakho futhi bakuqaphe eduze ngezimpawu zokuphuma kwegazi okukhulu.
Uma weqa umthamo we-caplacizumab, yithathe ngokushesha lapho ukhumbula, ngaphandle uma sekuseduze nesikhathi somthamo wakho olandelayo. Kulokho, weqa umthamo oweqiwe bese uqhubeka nohlelo lwakho olujwayelekile lokulinganisa. Ungalokothi uthathe imithamo emibili ngesikhathi esisodwa ukuze ulungise umthamo oweqiwe.
Xhumana nomhlinzeki wakho wezempilo ukuze ubazise ngomthamo oweqiwe, ikakhulukazi uma usesigabeni sokuqala sokwelashwa. Bangase bafune ukuqapha ukubalwa kwama-platelet akho eduze noma balungise uhlelo lwakho lokwelashwa ukuze baqinisekise ukuthi uthola inzuzo ephelele yomuthi.
Ungayeka ukuthatha i-caplacizumab lapho udokotela wakho enquma ukuthi ukubalwa kwama-platelet akho kuhlale kuzinzile futhi i-TTP yakho isekusithekeni. Lokhu kuvamile ukwenzeka ngemva kwezinsuku okungenani ezingama-30 zokwelashwa, uma ukubalwa kwama-platelet akho kuhlala ngaphezu kuka-150,000 ngemayikrolitha ngamashumi ambalwa ezinsuku.
Ithimba lakho lezempilo lizokwehlisa kancane ukuqapha njengoba usondela ekupheleni kokwelashwa, kodwa lizoqhubeka nokuhlola umsebenzi wakho wegazi njalo ngisho nangemva kokuyeka umuthi. Lokhu kusiza ukuqinisekisa ukuthi i-TTP yakho ayibuyi nokuthi ukubalwa kwegazi lakho kuhlala kuzinzile.
Ungalokothi uyeke i-caplacizumab ngokwakho, ngisho noma uzizwa ungcono kakhulu. I-TTP ingabuyela uma ukwelashwa kuyekwa ngaphambi kwesikhathi, ngakho-ke kubalulekile ukulandela isiqondiso sikadokotela wakho mayelana nokuthi kuphephile nini ukuyeka umuthi.
Abantu abaningi bangashayela ngokuphepha ngenkathi bethatha i-caplacizumab, kodwa kufanele uqaphele kakhulu, ikakhulu ezinsukwini zokuqala zokwelashwa. Abanye abantu bazizwa bekhathele noma benomuzwa wokucindezeleka okungase kuthinte ikhono labo lokushayela ngokuphepha.
Okukhathaza kakhulu yingozi eyengeziwe yokopha uma kwenzeka ingozi. Qiniseka ukuthi uzizwa uqaphile futhi uzinzile ngaphambi kokungena ngemuva kwesondo, futhi gwema ukushayela uma uhlangabezana nanoma yiziphi izimpawu ezikhathazayo njengezinhlungu zekhanda ezinzima, isiyezi, noma ukukhathala okungavamile.
Uma ushayela, gqoka ibhande lakho lokuphepha futhi gwema izimo zokushayela eziyingozi uma kungenzeka. Gcina imininingwane yokuxhumana yomhlinzeki wakho wezempilo iseduze uma udinga ukubafinyelela ngenkathi ungekho ekhaya.